Dr Loren Flynn is a postdoctoral research scientist and co-leads the Motor Neurone Disease Genetics and Therapeutics Research group with Professor Anthony Akkari which is based at the Perron Institute and at the Personalised Medicine Centre, Murdoch University. She joined the newly established MND group in 2017 after completing her PhD at UWA and the Perron Institute, under the supervision of Prof Steve Wilton and Prof Sue Fletcher.
Loren’s research focuses on identifying antisense oligonucleotide therapeutics for neurodegenerative diseases, including MND and Parkinson’s disease, targeting key mechanisms of disease pathology. Loren is currently the Director for Therapeutic Development with Black Swan Biotech, driving the pre-clinical development of their antisense therapy portfolio.

View Publications    Email